Patents by Inventor Susannah K. Rogers

Susannah K. Rogers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150231237
    Abstract: Methods and products for treating proliferative diseases, and wounds, using as a pharmacon an autophagy inhibitor, a glycolytic inhibitor, and/or an agent able to alter cellular production of reactive oxygen, or combination thereof, optionally in combination with one or more chemotherapeutic agents. In some embodiments, the invention combines a 4-aminoquinoline, exemplified by chloroquine, with a glycolytic inhibitor, exemplified by 2-deoxy-D-glucose and anti-VEGF antibodies.
    Type: Application
    Filed: May 5, 2015
    Publication date: August 20, 2015
    Applicant: The Regents of the University of Colorado, a body corporate
    Inventors: Martha Karen Newell-Rogers, Susannah K. Rogers
  • Patent number: 9073985
    Abstract: Methods and products for treating proliferative diseases, and wounds, using as a pharmacon an autophagy inhibitor, a glycolytic inhibitor, and/or an agent able to alter cellular production of reactive oxygen, or combination thereof, optionally in combination with one or more chemotherapeutic agents. In some embodiments, the invention combines a 4-aminoquinoline, exemplified by chloroquine, with a glycolytic inhibitor, exemplified by 2-deoxy-D-glucose and anti-VEGF antibodies. The systems and methods of the invention may be used to treat drug-resistant or multi-drug resistant cancers.
    Type: Grant
    Filed: July 14, 2009
    Date of Patent: July 7, 2015
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Martha Karen Newell, Susannah K. Rogers
  • Publication number: 20140234359
    Abstract: The invention relates to methods and related products for preventing and treating disease, based on the use of plant viral vaccines and plant viral defense strategies. The methods also involve the identification of appropriate therapeutic strategies for diseases such as cancers.
    Type: Application
    Filed: September 21, 2012
    Publication date: August 21, 2014
    Applicants: Viral Genetics, Inc., Scott & White Healthcare, The Texas A&M University System
    Inventors: Martha Karen Newell, Richard Tobin, Susannah K. Rogers
  • Publication number: 20110318335
    Abstract: Methods and products for treating proliferative diseases, and wounds, using as a pharmacon an autophagy inhibitor, a glycolytic inhibitor, and/or an agent able to alter cellular production of reactive oxygen, or combination thereof, optionally in combination with one or more chemotherapeutic agents. In some embodiments, the invention combines a 4-aminoquinoline, exemplified by chloroquine, with a glycolytic inhibitor, exemplified by 2-deoxy-D-glucose and anti-VEGF antibodies. The systems and methods of the invention may be used to treat drug-resistant or multi-drug resistant cancers.
    Type: Application
    Filed: July 14, 2009
    Publication date: December 29, 2011
    Applicant: The Regents of the University of Colorado
    Inventors: Martha Karen Newell, Susannah K. Rogers